Loading Calculator...
Please wait a moment
Please wait a moment
Assess cross-reactivity risk between medications and identify safe alternatives for patients with known drug allergies.
Optional: helps refine risk assessment
Drug cross-reactivity occurs when a patient allergic to one medication reacts to a structurally or mechanistically related drug. Understanding these patterns is crucial for safe prescribing and avoiding unnecessary drug restrictions.
Historical estimates of 10% cross-reactivity are outdated and led to unnecessary antibiotic restrictions. Modern data shows only 1-2% cross-reactivity overall. The shared beta-lactam ring is less important than R1 side chain similarity. Penicillins and cephalosporins with identical R1 side chains have higher cross-reactivity (up to 4%), while those with different side chains have minimal cross-reactivity.
Example: Amoxicillin and cephalexin share an R1 side chain, so cross-reactivity is possible. Amoxicillin and ceftriaxone have different R1 side chains, so cross-reactivity is unlikely.
Common misconception: many drugs contain sulfonamide moieties, but cross-reactivity between sulfonamide antibiotics (sulfamethoxazole) and non-antibiotic sulfonamides (furosemide, hydrochlorothiazide, sulfonylureas, celecoxib) is very low. The allergenic determinant differs - sulfonamide antibiotics have an N4 amine group that's absent in non-antibiotics.
Patients with sulfonamide antibiotic allergies can generally safely receive non-antibiotic sulfonamides. The increased reaction rate in some studies likely reflects multiple drug allergies rather than true cross-reactivity.
Two patterns exist:
Two distinct chemical classes exist:
No cross-reactivity between esters and amides. Most reported "local anesthetic allergies" are actually vasovagal reactions, anxiety, or reactions to preservatives (methylparaben) or epinephrine. True IgE-mediated local anesthetic allergy is rare.
Many patients carry inaccurate drug allergy labels that lead to use of broader-spectrum, more expensive, or less effective antibiotics. Allergy evaluation and de-labeling can expand safe treatment options. Penicillin allergy testing can remove the label in 90%+ of patients with reported penicillin allergies, allowing use of first-line antibiotics.
Most likely yes. Modern evidence shows only 1-2% cross-reactivity overall. Risk depends on the specific penicillin and cephalosporin (R1 side chain similarity) and your reaction type. Delayed, mild reactions have very low cross-reactivity risk. For immediate/severe reactions, allergy testing can clarify safety. Many patients with penicillin allergy labels are not truly allergic.
Penicillin allergy de-labeling involves evaluation (history, testing, challenge) to determine if a patient is truly allergic. Over 90% of patients with reported penicillin allergies can be de-labeled as non-allergic, often because the reaction occurred in childhood, was likely viral rash, or allergy has waned over time (IgE-mediated penicillin allergy can disappear after 10+ years of avoidance).
It depends which "sulfa drug." Non-antibiotic sulfonamides (furosemide, hydrochlorothiazide, sulfonylureas, celecoxib) have different chemical structures and very low cross-reactivity with sulfonamide antibiotics. They can generally be used safely. However, always inform your doctor about your allergy history for individualized risk assessment.
Possibly. If you tolerate aspirin or other NSAIDs, you likely have single-drug ibuprofen allergy and can use chemically different NSAIDs. If you react to multiple NSAIDs, you may have cross-reactive COX-1 inhibitor hypersensitivity. Selective COX-2 inhibitors (celecoxib) and acetaminophen are usually tolerated in cross-reactive NSAID hypersensitivity. Allergist evaluation can identify safe alternatives.
Drug allergy involves an immune system response (IgE-mediated, T-cell mediated). Drug intolerance or side effects are non-immune reactions (e.g., nausea from antibiotics, GI upset from NSAIDs). Side effects don't preclude future use or predict cross-reactivity. True allergies may require avoiding related drugs and have risk of severe reactions.
Consider testing if: (1) you need the drug or related drug for best treatment, (2) your reaction history is unclear or remote, (3) you carry a high-impact allergy label (penicillin) that limits treatment options. Testing is especially valuable for penicillin allergy. Allergist evaluation determines appropriate testing and safe alternatives.
Desensitization is a procedure where a drug is given in gradually increasing doses to temporarily induce tolerance in an allergic patient. Used when the drug is essential and no suitable alternative exists (e.g., penicillin for syphilis in pregnancy, aspirin for cardiac disease). Must be done in a controlled setting by allergy specialists. Tolerance lasts only while taking the drug continuously.
No. Genetic pharmacogenomic reactions (e.g., HLA-B*5701 and abacavir hypersensitivity, HLA-B*1502 and carbamazepine SJS in Asian populations) are immune-mediated but genetically determined. Testing for these HLA alleles can prevent reactions. These differ from traditional acquired drug allergies. Some severe drug reactions (SJS/TEN, DRESS) have genetic predisposition.
Assess food allergy risk and introduction timing
Track urticaria activity score
Assess eczema severity using SCORAD index
Calculate appropriate antibiotic doses
Calculate body surface area for psoriasis
Calculate Psoriasis Area and Severity Index